1. Home
  2. SAGE vs BLDP Comparison

SAGE vs BLDP Comparison

Compare SAGE & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • BLDP
  • Stock Information
  • Founded
  • SAGE 2010
  • BLDP 1979
  • Country
  • SAGE United States
  • BLDP Canada
  • Employees
  • SAGE N/A
  • BLDP N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • BLDP Industrial Machinery/Components
  • Sector
  • SAGE Health Care
  • BLDP Energy
  • Exchange
  • SAGE Nasdaq
  • BLDP Nasdaq
  • Market Cap
  • SAGE 462.2M
  • BLDP 383.2M
  • IPO Year
  • SAGE 2014
  • BLDP 1995
  • Fundamental
  • Price
  • SAGE $5.01
  • BLDP $1.31
  • Analyst Decision
  • SAGE Hold
  • BLDP Hold
  • Analyst Count
  • SAGE 20
  • BLDP 11
  • Target Price
  • SAGE $12.89
  • BLDP $2.27
  • AVG Volume (30 Days)
  • SAGE 854.9K
  • BLDP 4.3M
  • Earning Date
  • SAGE 10-29-2024
  • BLDP 11-05-2024
  • Dividend Yield
  • SAGE N/A
  • BLDP N/A
  • EPS Growth
  • SAGE N/A
  • BLDP N/A
  • EPS
  • SAGE N/A
  • BLDP N/A
  • Revenue
  • SAGE $106,399,000.00
  • BLDP $91,962,000.00
  • Revenue This Year
  • SAGE N/A
  • BLDP N/A
  • Revenue Next Year
  • SAGE $118.26
  • BLDP $25.65
  • P/E Ratio
  • SAGE N/A
  • BLDP N/A
  • Revenue Growth
  • SAGE 837.60
  • BLDP 24.01
  • 52 Week Low
  • SAGE $4.62
  • BLDP $1.23
  • 52 Week High
  • SAGE $28.26
  • BLDP $4.01
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 32.20
  • BLDP 37.44
  • Support Level
  • SAGE $4.62
  • BLDP $1.23
  • Resistance Level
  • SAGE $5.87
  • BLDP $1.42
  • Average True Range (ATR)
  • SAGE 0.39
  • BLDP 0.10
  • MACD
  • SAGE -0.10
  • BLDP -0.00
  • Stochastic Oscillator
  • SAGE 21.18
  • BLDP 12.28

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is a world leader in proton-exchange membrane fuel cells, power system development, and commercialization. The company's principal business is the design, development, manufacture, sale, and service of PEM fuel cell products for a variety of applications, focusing on power product markets of heavy-duty motive (bus, truck, rail, and marine applications), material handling, and stationary power generation. Sales are concentrated in the US, Europe, and China.

Share on Social Networks: